Showing results (291-300 of 306) with videos related to

Sort By:
Pageof 31
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2020
Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injuryLeonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 10, 2025
Quantitative Deauville Scoring to Uncover Prognostic Information from 18F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 TrialLars Kurch, Judith Landman-Parker, Thomas W Georgi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2021
Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsyMengmeng Song, Maximilian Scheifele, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear PalsyKonstantin Messerschmidt, Henryk Barthel, Matthias Brendel, et al.
Acta Neuropathologica|November 24, 2024
Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathiesLuna Slemann, Johannes Gnörich, Selina Hummel, et al.
JAMA Neurology|November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear PalsyMatthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 28, 2021
Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PETMengmeng Song, Leonie Beyer, Lena Kaiser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 14, 2022
Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndromeSabrina Katzdobler, Alexander Nitschmann, Henryk Barthel, et al.
Pageof 31